Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis

Urology

Volumn 67, Issue 6, 2006, Pages 1315-1319

  Imamoǧlu, Mustafa ^a   Cay, Ali ^a   Çobanoglu, Ümit ^a   Bahat, Elif ^a   Karahan, Caner ^a   Tosun, Ilknur ^a   Sarihan, Haluk ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; MALONALDEHYDE; MELATONIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; HISTOPATHOLOGY; INFLAMMATION; KIDNEY SCAR; MALE; NONHUMAN; PRIORITY JOURNAL; PYELONEPHRITIS; RAT; SCAR FORMATION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CICATRIX; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; KIDNEY DISEASES; MALE; MELATONIN; PYELONEPHRITIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33744508041     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.12.013     Document Type: Article

References (28)

1. Bennett R.T., Mazzaccaro R.J., Chopra N., et al. Suppression of renal inflammation with vitamins A and E in ascending pyelonephritis in rats. J Urol 161 (1999) 1681-1684
2. Jakobsson B., Berg U., and Svensson L. Renal scarring after acute pyelonephritis. Arch Dis Child 70 (1994) 111-115
3. Haraoka M., Matsumoto T., Takahashi, et al. Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. J Urol 151 (1994) 1078-1080
4. Pohl H.G., Rushton H.G., Park J.S., et al. Adjunctive oral corticosteroids reduce renal scarring. the piglet model of reflux and acute experimental pyelonephritis. J Urol 162 (1999) 815-820
5. Kavukçu S., Soylu A., Türkmen M., et al. The role of vitamin A in preventing renal scarring secondary to pyelonephritis. BJU Int 83 (1999) 1055-1059
6. Huang A., Palmer L.S., Hom D., et al. Ibuprofen combined with antibiotics suppresses renal scarring due to ascending pyelonephritis in rats. J Urol 162 (1999) 1396-1398
7. Yaǧmurlu A., Boleken M.E., Ertoy D., et al. Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis. Urology 61 (2003) 1037-1041
8. Gitto E., Reiter R.J., Amodio A., et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res 36 (2004) 250-255
9. Fulia F., Gitto E., Cuzzocrea S., et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns. reduction by melatonin. J Pineal Res 31 (2001) 343-349
10. Reiter R.J., Tan D., Osuna C., et al. Actions of melatonin in the reduction of oxidative stress. J Biomed Sci 7 (2000) 444-458
11. Cuzzocrea S., and Reiter R.J. Pharmacological actions of melatonin in acute and chronic inflammation. Curr Top Med Chem 2 (2002) 153-165
12. Drake M.J., Mills I.W., and Noble J.G. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol 171 (2004) 1199-1202
13. Tan D., Manchester L.C., Hardeland R., et al. Melatonin. a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 34 (2003) 75-78
14. Jan J.E., Hamilton D., Seward N., et al. Clinical trials of control release melatonin in children with sleep-wake cycle disorders. J Pineal Res 29 (2000) 34-39
15. Yavuz M.N., Yavuz A.A., Ülkü C., et al. Protective effect of melatonin against fractionated irradiation-induced epiphyseal injury in a weanling rat model. J Pineal Res 35 (2003) 288-294
16. Okur H., Köse Ö., Kula M., et al. The role of infection and free oxygen radical damage in reflux nephropathy. an experimental study. J Urol 169 (2003) 1874-1877
17. Matsumoto T., Mizunoe Y., Ogata N., et al. Role of superoxide in renal scarring following infection by mannose-sensitive piliated bacteria. Urol Res 19 (1991) 229-233
18. Roberts J. Vesicoureteral reflux and pyelonephritis in the monkey. a review. J Urol 148 (1992) 1721-1725
19. Mihara M., and Uchiyama M. Determination of malondialdehyde precursor in tissues by thiobarbitiric acid test. Anal Biochem 86 (1978) 271-278
20. McCall M.R., and Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans?. Free Rad Biol Med 26 (1999) 1034-1053
21. Reiter R.J., Tan D.X., Manchester L.C., et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. a review of the evidence. Cell Biochem Biophys 34 (2001) 237-256
22. Rodriguez C., Mayo J.C., Sainz R.M., et al. Regulation of antioxidant enzymes. a significant role for melatonin. J Pineal Res 36 (2004) 1-9
23. Pei Z., Pang S.F., and Cheung R.T.F. Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. J Pineal Res 32 (2002) 168-172
24. Kabore A.F., Simard M., and Bergeron M.G. Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis. J Infect Dis 179 (1999) 1162-1172
25. Roberts J.A., Roth J.K., Domingue G., et al. Immunology of pyelonephritis in the primate model. V. Effect of superoxide dismutase. J Urol 128 (1982) 1394-1400
26. Sahna E., Parlakpinar H., Ozturk F., et al. The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol Res 31 (2003) 188-193
27. Sener G., Sehirli A., Keyer-Uysal M., et al. The protective effect of melatonin on renal ischemia-reperfusion injury in the rat. J Pineal Res 32 (2002) 120-126
28. Kunduzova O.R., Escourrou G., Seguelas M.H., et al. Prevention of apoptotic and necrotic cell death, caspase-3 activation, and renal dysfunction by melatonin after ischemia/reperfusion. FASEB J 17 (2003) 872-874